scholarly article | Q13442814 |
P2093 | author name string | C F Dietrich | |
A Ignee | |||
J Trojan | |||
G Schuessler | |||
C Fellbaum | |||
P2860 | cites work | Bacillary angiomatosis of the liver, a suspected ultrasound diagnosis? | Q40612353 |
Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. | Q42984210 | ||
Sonographic findings of the hepatobiliary-pancreatic system in adult patients with cystic fibrosis | Q43947962 | ||
Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging | Q67973184 | ||
Prospective comparison of preoperative imaging and intraoperative ultrasonography in the detection of liver tumors | Q69359315 | ||
Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study | Q73155172 | ||
Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases | Q73535910 | ||
Phase-inversion sonography during the liver-specific late phase of contrast enhancement: improved detection of liver metastases | Q73781851 | ||
Contrast enhanced power Doppler sonography: comparison of various administration forms of the ultrasound contrast agent Levovist | Q73941077 | ||
B-mode enhancement at phase-inversion US with air-based microbubble contrast agent: initial experience in humans | Q73972012 | ||
Stimulated acoustic emission in liver parenchyma with Levovist | Q74282334 | ||
Multiple adenomas and hepatocellular carcinoma in a renal transplant patient with glycogen storage disease type 1a (von Gierke disease) | Q74286389 | ||
Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience | Q74433405 | ||
Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C | Q77051786 | ||
Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience | Q77337291 | ||
Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver | Q78397096 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 401-405 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Gut | Q5621669 |
P1476 | title | Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. | |
P478 | volume | 53 |
Q53357444 | A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma. |
Q26860623 | Alcohol and hepatocellular carcinoma: a review and a point of view |
Q36980220 | Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography |
Q30433022 | Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI |
Q28084620 | Benign liver lesions: grey-scale and contrast-enhanced ultrasound appearances |
Q26801185 | Benign liver tumors in pediatric patients - Review with emphasis on imaging features. |
Q52941050 | Characterization of hyperechoic focal liver lesions: quantitative evaluation with pulse inversion harmonic imaging in the late phase of levovist. |
Q93059908 | Combination of CEUS and MRI for the diagnosis of periampullary space-occupying lesions: a retrospective analysis |
Q50543212 | Contrast enhanced ultrasound features of hepatic cystadenoma and hepatic cystadenocarcinoma. |
Q30478161 | Contrast enhanced ultrasound of renal masses |
Q38083837 | Contrast-Enhanced Ultrasound for the differentiation of benign and malignant focal liver lesions: a meta-analysis |
Q47391871 | Contrast-enhanced US for characterization of focal liver lesions: a comprehensive meta-analysis |
Q30361965 | Contrast-enhanced endobronchial ultrasound: Potential value of a new method. |
Q33788129 | Contrast-enhanced endoscopic ultrasound in discrimination between focal pancreatitis and pancreatic cancer |
Q53583559 | Contrast-enhanced ultrasonography in hepatic angiomyolipoma. |
Q51648265 | Contrast-enhanced ultrasonography with SonoVue: differentiation between benign and malignant lesions of the spleen. |
Q30421027 | Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. |
Q30455788 | Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases |
Q36909256 | Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma. |
Q53484750 | Contrast-enhanced ultrasound of histologically proven liver hemangiomas. |
Q30455431 | Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions |
Q30488974 | Current role of ultrasound for the management of hepatocellular carcinoma |
Q30478166 | Detection of focal liver lesions in cirrhotic liver using contrast-enhanced ultrasound |
Q53576054 | Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. |
Q26851954 | Fortuitously discovered liver lesions |
Q97881581 | Guidelines and Good Clinical Practice Recommendations for Contrast-Enhanced Ultrasound (CEUS) in the Liver-Update 2020 WFUMB in Cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS |
Q34604513 | Guidelines for contrast enhanced ultrasound (CEUS)--update 2008 |
Q41126839 | Hepatic malignancies: Correlation between sonographic findings and pathological features |
Q83286864 | Heterogeneity of microbubble accumulation: a novel approach to discriminate between well-differentiated hepatocellular carcinomas and regenerative nodules |
Q49165838 | How to perform Contrast-Enhanced Ultrasound (CEUS). |
Q63351040 | Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound |
Q51050880 | Improvement in the routine diagnostic assessment of the liver by high-resolution sonography: an analysis of 999 cases. |
Q51719692 | Intensity-Based Assessment of Microbubble-Enhanced Ultrasonography: Phase-Related Diagnostic Ability for Cellular Differentiation of Hepatocellular Carcinoma. |
Q52990527 | Liver Contrast-Enhanced Ultrasound Improves Detection of Liver Metastases in Patients with Pancreatic or Periampullary Cancer. |
Q36332207 | Pictorial review: sonographic patterns of diffuse and focal fatty infiltration of the liver: differential diagnosis to metastatic liver disease |
Q30433373 | Prospective study of differential diagnosis of hepatic tumors by pattern-based classification of contrast-enhanced sonography |
Q38082982 | Radiofrequency ablation of liver metastases from colorectal cancer: a literature review |
Q36579630 | Recent applications of ultrasound: diagnosis and treatment of hepatocellular carcinoma |
Q53362427 | Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index. |
Q36778695 | Technology insight: advances in liver imaging |
Q38922933 | Temporal regularization of ultrasound-based liver motion estimation for image-guided radiation therapy |
Q44021980 | Terminology for contrast-enhanced sonography: a practical glossary |
Q58618414 | Ultrasound Imaging of Hepatocellular Adenoma Using the New Histology Classification |
Q28077669 | Ultrasound contrast agents |
Q30465459 | Vascularisation pattern of chronic pancreatitis compared with pancreatic carcinoma: results from contrast-enhanced endoscopic ultrasound |
Q53566652 | [Guidelines for the use of contrast agents in ultrasound] |